about
Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganizationA new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosisActivation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytesLithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.Bile acid-induced Mallory body formation in drug-primed mouse liver.The keratin cytoskeleton in liver diseases.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Selectivity of biopolymer membranes using HepG2 cells.Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: review of a historical cohort.Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line.Arsenite induced oxidative damage in mouse liver is associated with increased cytokeratin 18 expression.Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation.Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.Alteration of bile acid and cholesterol biosynthesis and transport by perfluorononanoic acid (PFNA) in mice.Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet.
P2860
Q28512838-DE34E5BF-9232-4CF8-81CA-14E20B786BDDQ30479829-0EBD4368-967E-4642-90E8-41E629D64B23Q33343363-E692ABD8-EE55-47A6-A8C7-A720A3F3ED92Q35087943-E5B67B78-CBE6-4A07-85BB-E9B50B7A7339Q35748180-F5522442-5304-4695-B629-567DA136385BQ35923530-8EB69F93-6E51-40BB-B3B9-B4E7C838C478Q36197335-E6C6C650-119F-4086-A096-8E36761DCB2BQ36345161-C8861676-A8AA-4387-9C63-CD9199B0CEA6Q37350688-38AF1393-670E-41E0-967B-8C42F67553DAQ39989851-24266F91-AB27-4A3E-9072-9F1864BF6B1DQ40162900-75CCF930-208A-4530-8C52-0A15008C5FF1Q40536314-E7FBF289-A8D0-4D31-96EA-5C52582C1684Q42417111-0B88E7DD-E6E8-46BD-8EE7-8EBD7DE2A875Q50026411-7F6B33D0-9011-4706-B2B1-15C6277D2496Q50082945-96CFB9B2-BA21-4D28-B3E5-5862EBA3BCAC
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Cytokeratins as targets for bile acid-induced toxicity.
@ast
Cytokeratins as targets for bile acid-induced toxicity.
@en
type
label
Cytokeratins as targets for bile acid-induced toxicity.
@ast
Cytokeratins as targets for bile acid-induced toxicity.
@en
prefLabel
Cytokeratins as targets for bile acid-induced toxicity.
@ast
Cytokeratins as targets for bile acid-induced toxicity.
@en
P2093
P2860
P1476
Cytokeratins as targets for bile acid-induced toxicity.
@en
P2093
Andrea Fuchsbichler
Conny Stumptner
Helmut Denk
Michael Trauner
Peter Fickert
P2860
P304
P356
10.1016/S0002-9440(10)64868-7
P407
P577
2002-02-01T00:00:00Z